|
TIOTROPIUM
HANDIHALER |
Tiotropium inhalation powder is recommended for addition to formulary. It is
more effective than ipratropium inhalation aerosol and salmeterol inhalation
powder when compared by FEV1, PEFR, functional residual capacity,
duration of action, tachyphylaxis, health related quality of life, and
concomitant use of bronchodilators. It has a low incidence of side effects with
dry mouth being most common. It is 3.3 times more expensive than ipratropium. It
is administered once daily. Patients should not receive tiotropium and
ipratropium concurrently.
|